Welcome to our dedicated page for Interparfums SEC filings (Ticker: IPAR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Interparfums bottles prestige for names like Coach, Jimmy Choo, and Montblanc, yet the real fragrance of insight lies inside its SEC disclosures. Currency swings between its European and U.S. segments, contractual royalty rates, and license expiry dates all surface deep in the footnotes. If you have ever searched for “Interparfums annual report 10-K simplified� or tried to trace brand sales through a dense 10-K, you know why clarity matters.
Stock Titan turns that hunt into clarity. Our AI reviews every Interparfums quarterly earnings report 10-Q filing, flags segment revenue shifts, and delivers “Interparfums SEC filings explained simply� within minutes. The same engine pushes alerts on “Interparfums insider trading Form 4 transactions� and streams “Interparfums Form 4 insider transactions real-time� so you see moves as they happen. Looking for an “Interparfums earnings report filing analysis�? It sits next to “Interparfums 8-K material events explained� whenever a new license or manufacturing update hits EDGAR.
The result: more decision time, less decoding time. Whether you’re “understanding Interparfums SEC documents with AI,â€� reviewing “Interparfums proxy statement executive compensation,â€� or tracking “Interparfums executive stock transactions Form 4,â€� our platform delivers context, numbers, and professional commentary in one place. AGÕæÈ˹ٷ½-time EDGAR feeds, AI-powered summaries, and intuitive dashboards let you:
- Monitor insider buying before product launches
- Compare fragrance-brand royalties quarter over quarter
- Assess currency impacts across regions
Global Lights Acquisition Corp (GLACU) has been formally removed from listing and registration on the Nasdaq Stock Market. Nasdaq filed Form 25 on 14 July 2025, citing compliance with Rule 12d2-2 under the Securities Exchange Act of 1934. The action covers the company’s Ordinary Shares, Units and Rights. The filing is signed by Nasdaq Hearings Advisor Aravind Menon, confirming the exchange believes all regulatory requirements for delisting have been satisfied.
The document does not disclose the reason for the delisting or provide financial data; it merely certifies regulatory compliance for striking the securities from the exchange. Investors should note that, once effective, GLACU securities will no longer trade on Nasdaq and will lose Exchange Act Section 12(b) registration.
Director Harrison Gilbert of Interparfums reported the following transactions and holdings:
Transaction Details:
- Sold 400 shares of common stock at $133.96 per share on June 23, 2025
- Reduced direct ownership from 1,950 to 1,550 shares following the transaction
Options Portfolio:
- Holds multiple tranches of stock options with strike prices ranging from $62.18 to $147.71
- Total options rights for 5,700 shares across various expiration dates (2026-2030)
- Options vest in stages, with exercise prices reflecting different grant periods: - $62.18 options expire 2026 - $97.84 options expire 2028 - $147.71 options expire 2029 - $130.60 options expire 2030
Inter Parfums, Inc. (IPAR) has filed a Form 144 notice with the U.S. Securities and Exchange Commission.
The filing discloses a proposed sale of 400 common shares through Oppenheimer & Co. at an aggregate market value of $53,429. The shares were originally acquired on 17 Jan 2025 as compensation. The filer intends to execute the sale on or about 23 Jun 2025 on the NASDAQ exchange.
According to the notice, Inter Parfums has 32.124 million shares outstanding; therefore, the planned disposition represents approximately 0.001 % of the total share count. No additional sales have been reported during the prior three-month period, and no remarks or signatures were included in the excerpt provided.
The Form 144 also contains the standard representation that the seller is unaware of any undisclosed material adverse information regarding the issuer.